ArticleJournal of medical case reports2026
Conservative management of mad honey poisoning presenting with bradycardia: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMad honey is a type of honey with hallucinogenic properties found in the Himalayas of Nepal. It is used by locals for its supposedly medical and recreational properties. It contains a toxin named 'Grayanotoxin' which is mainly derived from the nectar of few Rhododendron species native to Himalayas. CASE PRESENTATION: This is a case report of 38-year-old male who presented to emergency department of our center with dizziness, three hours following ingestion of mad honey. He had heart rate of 45 beats per minute. Electrocardiogram showed bradycardia without any other abnormality. He was managed conservatively in coronary care unit for 48 h without any complication. CLINICAL DISCUSSION: "Grayanotoxin" is a neurotoxin that acts on voltage-gated sodium channels, preventing their inactivation and causing persistent depolarization, leading to a wide range of symptoms. Management is symptomatic as no antidotes are available till date. Early recognition prevents unnecessary investigations and interventions.
conclusionMad honey poisoning should always be considered in patient particularly those living in endemic areas presenting with unexplained dizziness and bradycardia. Most of these cases respond well to supportive therapy emphasizing the importance of early recognition and close clinical observation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.